DRW Securities’s Medtronic MDT Stock Holding History

DRW Securities’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-11,100	Closed	-$870K	–	401
2023 Q3	$870K	Buy	+11,100	New	+$929K	0.02%	163
2023 Q2	–	Sell	-6,000	Closed	-$484K	–	413
2023 Q1	$484K	Buy	+6,000	New	+$489K	0.01%	206

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

DRW Securities's MDT Position: Q2 2026 in Review

DRW Securities sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,545 shares — an estimated $221K sold.

DRW Securities first reported a position in MDT in Q4 2017 and held it in 15 quarters. The position peaked at $1.53M in Q4 2017. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

DRW Securities reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
DRW Securities sold 2,545 Medtronic shares in Q2 2026, an estimated $221K.
DRW Securities first reported a position in Medtronic in Q4 2017 and held it in 15 quarters.
DRW Securities's Medtronic position peaked at $1.53M in Q4 2017.
2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.